Please login to the form below

Not currently logged in
Email:
Password:

VCLS appoints Carole Jones to senior market access role

She joins from Envision Pharma Group

Carole JonesGlobal product development consultancy Voisin Consulting Life Sciences (VCLS) has appointed Carole Jones as its Diretor of Market Access in a role that will see her focus on expanding the company’s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support.

She said: “I am delighted to be part of an organisation with such an active focus on the integration of payer evidence requirements into clinical development programmes for our clients.

“The combination of world class regulatory and health economics expertise allows us to be powerful advocates for our clients in navigating the complex, evolving pharmaceutical environment.

“The goal of delivering innovative therapies and making them accessible to patients is at the forefront of the company’s and my own vision.”

Jones previously worked for a variety of biotech, pharma and service companies including Novlion Therapeutics (formerly QLT), QuintilesIMS (formerly IMS Health) and Envision Pharma Group, where she was involved in publication strategy, development of manuscripts and white papers for peer-reviewed journals, systematic literature reviews, global value dossiers and interactive field-based assets.

Emmanuelle Voisin, founder and CEO of VCLS, said: “We at VCLS are excited about the appointment of Carole Jones and the opportunities it will bring.

“The extensive experience Carole brings will strengthen our capabilities and put us at the forefront of integrated pharmaceutical development strategy.”

23rd May 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...